Joseph LaRosa

Insider Reports History

Location
Tarrytown, NY
Signature
/s/ Joseph LaRosa
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joseph LaRosa:

Company Role Class Num Shares Value Price $ Report Date Ownership
REGENERON PHARMACEUTICALS, INC. EVP General Counsel and Secret Common Stock 29,517 $21,043,849 $712.94 08 Dec 2025 Direct
REGENERON PHARMACEUTICALS, INC. EVP General Counsel and Secret Common Stock 9,000 $7,061,490 $784.61 05 Dec 2025 By 2025 GRAT
REGENERON PHARMACEUTICALS, INC. EVP General Counsel and Secret Common Stock 3,402 $2,669,243 $784.61 05 Dec 2025 By 2024 GRAT
REGENERON PHARMACEUTICALS, INC. EVP General Counsel and Secret Common Stock 396 $310,705 $784.61 05 Dec 2025 By 401(k) Plan
REGENERON PHARMACEUTICALS, INC. EVP General Counsel and Secret Non-Qualified Stock Option (right to buy) 12,210 05 Dec 2025 Direct

Insider Reports Filed by Joseph LaRosa

Symbol Company Period Transactions Value $ Form Type Role Filing Time
REGN REGENERON PHARMACEUTICALS, INC. 05 Dec 2025 3 -$995,264 4 EVP General Counsel and Secret 09 Dec 2025, 16:09
REGN REGENERON PHARMACEUTICALS, INC. 20 Nov 2025 3 -$1,317,233 4 EVP General Counsel and Secret 24 Nov 2025, 16:07
REGN REGENERON PHARMACEUTICALS, INC. 16 Dec 2024 1 -$513,029 4 EVP General Counsel and Secret 18 Dec 2024, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 06 Dec 2024 3 -$387,204 4 EVP General Counsel and Secret 10 Dec 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 11 Jul 2024 1 -$2,031,981 4 EVP General Counsel and Secret 12 Jul 2024, 16:00
REGN REGENERON PHARMACEUTICALS, INC. 24 Jun 2024 3 -$3,721,049 4 EVP General Counsel and Secret 25 Jun 2024, 16:39
REGN REGENERON PHARMACEUTICALS, INC. 10 Jun 2024 1 $0 4 EVP General Counsel and Secret 12 Jun 2024, 16:10
REGN REGENERON PHARMACEUTICALS, INC. 21 May 2024 1 -$1,855,488 4 EVP General Counsel and Secret 22 May 2024, 16:02
REGN REGENERON PHARMACEUTICALS, INC. 26 Feb 2024 1 -$990,000 4 EVP General Counsel and Secret 28 Feb 2024, 16:04
REGN REGENERON PHARMACEUTICALS, INC. 22 Feb 2024 1 -$967,650 4 EVP General Counsel and Secret 26 Feb 2024, 16:07
REGN REGENERON PHARMACEUTICALS, INC. 07 Feb 2024 1 -$950,000 4 EVP General Counsel and Secret 09 Feb 2024, 16:12
REGN REGENERON PHARMACEUTICALS, INC. 03 Jan 2024 3 -$8,756,524 4 EVP General Counsel and Secret 04 Jan 2024, 16:19
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2023 4 -$1,283,605 4 EVP General Counsel and Secret 12 Dec 2023, 16:01
REGN REGENERON PHARMACEUTICALS, INC. 23 Mar 2023 3 -$2,700,020 4 EVP General Counsel and Secret 27 Mar 2023, 16:39
REGN REGENERON PHARMACEUTICALS, INC. 10 Mar 2023 1 $0 4 EVP General Counsel and Secret 14 Mar 2023, 16:08
REGN REGENERON PHARMACEUTICALS, INC. 16 Dec 2022 2 $0 4 EVP General Counsel and Secret 20 Dec 2022, 15:07
REGN REGENERON PHARMACEUTICALS, INC. 09 Dec 2022 1 -$370,614 4 EVP General Counsel and Secret 13 Dec 2022, 15:12
REGN REGENERON PHARMACEUTICALS, INC. 09 Sep 2022 3 -$7,039,901 4 EVP General Counsel and Secret 12 Sep 2022, 16:30
REGN REGENERON PHARMACEUTICALS, INC. 07 Apr 2022 1 -$3,687,705 4 EVP General Counsel and Secret 11 Apr 2022, 16:41
REGN REGENERON PHARMACEUTICALS, INC. 01 Apr 2022 15 -$3,532,373 4 EVP General Counsel and Secret 04 Apr 2022, 16:04
REGN REGENERON PHARMACEUTICALS, INC. 11 Dec 2021 1 -$463,045 4 EVP General Counsel and Secret 14 Dec 2021, 15:07
REGN REGENERON PHARMACEUTICALS, INC. 08 Dec 2021 5 -$7,618,479 4 EVP General Counsel and Secret 10 Dec 2021, 16:30
REGN REGENERON PHARMACEUTICALS, INC. 20 Aug 2021 6 -$4,846,906 4 EVP General Counsel and Secret 24 Aug 2021, 16:06
REGN REGENERON PHARMACEUTICALS, INC. 02 Jul 2021 4 -$4,023,224 4 EVP General Counsel and Secret 07 Jul 2021, 16:01